Compositions and methods for modifying genomes
Compositions and methods for modifying genomic DNA sequences are provided. The methods produce double-stranded breaks (DSBs) at pre-determined target sites in a genomic DNA sequence, resulting in mutation, insertion, and/or deletion of DNA sequences at the target site(s) in a genome. Compositions comprise DNA constructs comprising nucleotide sequences that encode a Cms1 protein operably linked to a promoter that is operable in the cells of interest. The DNA constructs can be used to direct the modification of genomic DNA at pre-determined genomic loci. Methods to use these DNA constructs to modify genomic DNA sequences are described herein. Additionally, compositions and methods for modulating the expression of genes are provided. Compositions comprise DNA constructs comprising a promoter that is operable in the cells of interest operably linked to nucleotide sequences that encode a mutated Cms1 protein with an abolished ability to produce DSBs, optionally linked to a domain that regulates transcriptional activity. The methods can be used to up- or down-regulate the expression of genes at predetermined genomic loci.
1. A method of modifying a nucleotide sequence at a target site in the genome of a eukaryotic cell comprising:
introducing into said eukaryotic cell
(i) a DNA-targeting RNA, or a DNA polynucleotide encoding a DNA-targeting RNA, wherein the DNA-targeting RNA comprises: (a) a first segment comprising a nucleotide sequence that is complementary to a sequence in the target DNA; and (b) a second segment that interacts with a Cms1 polypeptide; and
(ii) a Cms1 polypeptide, or a polynucleotide encoding a Cms1 polypeptide, wherein the Cms1 polypeptide comprises: (a) an RNA-binding portion that interacts with the DNA-targeting RNA; and (b) an activity portion that exhibits site-directed enzymatic activity,
wherein said Cms1 polypeptide has at least 95% identity with the sequence set forth in SEQ ID NO: 62, and has Cms1 nuclease activity, wherein said method modifies said nucleotide sequence at said target site, and wherein said genome of a eukaryotic cell is a nuclear, plastid, or mitochondrial genome.
2. A method of modifying a nucleotide sequence at a target site in the genome of a prokaryotic cell comprising:
introducing into said prokaryotic cell
(i) a DNA-targeting RNA, or a DNA polynucleotide encoding a DNA-targeting RNA, wherein the DNA-targeting RNA comprises: (a) a first segment comprising a nucleotide sequence that is complementary to a sequence in the target DNA; and (b) a second segment that interacts with a Cms1 polypeptide; and
(ii) a Cms1 polypeptide, or a polynucleotide encoding a Cms1 polypeptide, wherein the Cms1 polypeptide comprises: (a) an RNA-binding portion that interacts with the DNA-targeting RNA; and (b) an activity portion that exhibits site-directed enzymatic activity,
wherein said Cms1 polypeptide has at least 95% identity with the sequence set forth in SEQ ID NO: 62, and has Cms1 nuclease activity, wherein said genome of a prokaryotic cell is a chromosomal, plasmid, or other intracellular DNA sequence, and wherein said prokaryotic cell is not the natural host of a gene encoding said Cms1 polypeptide.
3. The method of claim 1 wherein said eukaryotic cell is a plant cell.
4. The method of claim 3 , further comprising:
culturing the plant cell to produce a plant under conditions in which the Cms1 polypeptide is expressed and cleaves the nucleotide sequence at the target site to produce a modified nucleotide sequence; and
selecting a plant comprising said modified nucleotide sequence.
5. The method of claim 1 , wherein said Cms1 polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 62.
6. The method of claim 2 , wherein said Cms1 polypeptide comprises the amino acid sequence set forth in SEQ ID NO: 62.
7. The method of claim 1 , wherein said modified nucleotide sequence comprises insertion of heterologous DNA into the genome of the cell, deletion of a nucleotide sequence from the genome of the cell, or mutation of at least one nucleotide in the genome of the cell.
8. The method of claim 2 , wherein said modified nucleotide sequence comprises insertion of heterologous DNA into the genome of the cell, deletion of a nucleotide sequence from the genome of the cell, or mutation of at least one nucleotide in the genome of the cell.
9. A nucleic acid molecule comprising a polynucleotide sequence encoding a Cms1 polypeptide, wherein said polynucleotide sequence has at least 95% identity with the nucleic acid sequence set forth in SEQ ID NO: 142, or wherein said polynucleotide sequence encodes a Cms1 polypeptide with at least 95% identity to the amino acid sequence set forth in SEQ ID NO: 62, and has Cms1 nuclease activity, and wherein said polynucleotide sequence encoding a Cms1 polypeptide is operably linked to a promoter that is heterologous to the polynucleotide sequence encoding a Cms1 polypeptide.
10. The nucleic acid molecule of claim 9 wherein said nucleic acid molecule comprising a polynucleotide sequence encoding a Cms1 polypeptide comprises the nucleic acid set forth in SEQ ID NO: 142, or encodes a Cms1 polypeptide that comprises the amino acid sequence set forth in SEQ ID NO: 62.
11. A plant cell, eukaryotic cell, or prokaryotic cell comprising the nucleic acid molecule of claim 9 .
12. A plant cell, eukaryotic cell, or prokaryotic cell comprising the nucleic acid molecule of claim 10 .
13. A plant comprising the nucleic acid molecule of claim 9 .
14. A plant comprising the nucleic acid molecule of claim 10 .
15. The seed of the plant of claim 13 , wherein the seed comprises said nucleic acid molecule.
16. The nucleic acid molecule of claim 9 wherein said polynucleotide sequence encoding a Cms1 polypeptide is codon-optimized for expression in a plant cell.